Genta (company)

Genta Inc. is a biopharmaceutical company based in Berkeley Heights, New Jersey, United States, which develops products for the treatment of patients with cancer.

Its products include:
 * Genasense (development stage anticancer oblimersen sodium injection)


 * Tesetaxel (development stage anticancer oral tubulin inhibitor)


 * Ganite (Genta's only U.S. Food and Drug Administration (FDA) approved drug, is a gallium nitrate injection for treatment of cancer-related hypercalcemia)

Financial record
In addition to financing agreements with institutional investors, through its history, Genta Inc., like most listed unprofitable development stage start ups, has made reverse stock splits and stock dilution in order to get financial resources and stay afloat. For example, in July 2009, the company implemented a reverse stock split, which replaced 50 old shares with one new share.